The Jan. 28 warning applies to CovClear COVID-19 Rapid Antigen Test and the ImmunoPass COVID-19 Neutralizing Antibody Rapid Test.
Neither test has been authorized, cleared or approved by the FDA for use in the U.S. Empowered Diagnostics, the tests’ maker, issued a Class I recall for the tests, the most serious type.
The FDA said clinicians should consider retesting any patients given either rapid diagnostic test less than two weeks ago due to the risk of false results.
Learn more here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
